9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Serum Biomarkers in Diagnosis of Mesothelioma

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Serum Biomarkers in Diagnosis of Mesothelioma

Serum Biomarkers in Diagnosis of Mesothelioma

Estimated reading time: < 1 min

Condition: Mesothelioma

Estimated Enrollment: 230

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Completed

Study Results: No Results Available

Outcome Measures: Serum N-ERC/mesothelin, C-ERC/mesothelin, hyaluronan, osteopontin and syndecan -1 level in the patients with mesothelioma, metastatic malignant pleural diseases, benign pleural diseases, and benign asbestos pleurisy.,  ,  ,

Interventions: Mesothelin, hyaluronan, osteopontin, syndecan-1,

Phase:

Study Type: Observational

Study Design: Observational Model: Case-Only, Time Perspective: Retrospective, ,

Primary Completion Date: December 2010

Completion Date: October 2013

Last  Posted Date: January 7, 2014

Location: ESOGU Lung and Pleural Cancer Application and Research Center, Eskisehir, Turkey

Website Link: https://ClinicalTrials.gov/show/NCT02029105

Was this article helpful?
Dislike 0